NEW YORK, NY / ACCESSWIRE / July 23, 2015 / Aeterna Zentaris (NASDAQ: AEZS), CytRx Corporation (NASDAQ: CYTR), Synthetic Biologics Inc. (NYSE: SYN) are three tickers that have recently attracted attention in the Biotech space.
Biotech has mimicked the dot com boom of the early 2000's quite closely. Several biotech indices and ETFs have shown remarkable growth and have certainly outplaced the overall market. However, growth of this proportion leads to instabilities and overvaluation of many companies. This is exemplified in each of the three companies in focus. AEZS is trading near a 52 – week low after the company received disappointing results from the FDA. Similarly, CtyRx recently announced an offering in which management offered shares at a significant discount to the market price which resulted in the declines in the stock price. The biotech sector is full of speculation and blind money has been attracted solely by the returns published by both ETFs and Indices that follow this sector. The growth rates will decline and the boom will fall back in line with the market, but some will standout and continue to achieve growth of tremendous proportions.
To pick out the winners, a strict set of characteristics need to be in place. These include strong management backing, a diverse pipeline of drugs entering various stages of development, strength in the balance sheet and liquidity. Those that possess these characteristics can and will follow their own trajectory and will leave the high growing and unstable Biotech market behind.
For a more detailed research report with analyst comments and recommendation on the Biotech Sector and specifically the 3 companies mentioned please follow the link. There is no cost obligation required to view analyst report.
http://bit.ly/_Biotech_Analyst_Report
About Broad Street Alerts
We make the connection between sophisticated investors and high quality micro and small cap companies. An issuer of reports that provide a straightforward assessment of the profiled company. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges.
Safe Harbor Statement
This press release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to anticipated revenues, expenses, earnings, operating cash flows, the outlook for markets and the demand for products. Forward-looking statements are no guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statements. Such statements are based upon, among other things, assumptions made by, and information currently available to, management, including management's own knowledge and assessment of the Company's industry and competition. The Company refers interested persons to its most recent Annual Report on Form 10-K and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The company assumes no duty to update its forward-looking statements
Compliance Procedure
Content is researched, written and reviewed on a best-effort basis by a 3rd party research analyst. However, we are only human and may make mistakes. This report was prepared for informational purposes only. A full disclaimer can be found by viewing the full analyst report. We do not hold any positions and have not been compensated in any form for this press release and coinciding reports. For more information and services provided beyond this press release please use contact information provided below. If you notice any errors or omissions, please notify us.
Contact:
editor@broadstreetalerts.com
SOURCE: Broad Street Alerts
